LA JOLLA PHARMACEUTICAL CO Contracts & Agreements

148 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Agreement and Plan of Merger by and among the Parent, the Purchaser and the Company, dated as of July 10, 2022
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2022
Support Agreement, dated as of July 10, 2022, by and among the Parent, the Purchaser and the stockholders named therein
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2022
Description of Securities
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2022
Amended Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2021
PAION AG Exclusive Licensing Agreement, dated January 12, 2021
LA JOLLA PHARMACEUTICAL CO
2021
License Agreement, dated as of August 3, 2006, by and between the Registrant and the President and Fellows of Harvard College, as amended
License Agreements
LA JOLLA PHARMACEUTICAL CO
2021
Amendment, dated as of December 5, 2017, by and between the Registrant and the President and Fellows of Harvard College, as amended
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2021
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Larry Edwards dated as of July 28, 2020
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2020
Contingent Value Rights Agreement, dated as of July 17, 2020, between La Jolla Pharmaceutical Company and American Stock Transfer & Trust Company, LLC, as Rights Agent
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2020
Agreement and Plan of Merger by and among the La Jolla, Merger Sub and Tetraphase, dated June 24, 2020
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2020
Form of Contingent Value Rights Agreement, by and between La Jolla and the Rights Agent
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2020
Form of Support Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the stockholder named therein
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2020
Form of Exchange Agreement, dated June 24, 2020, by and among La Jolla, Merger Sub and the holder named therein
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2020
Description of Securities
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2020
Form of Indemnification Agreement
Indemnification Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2020
Employment Offer Letter by and between La Jolla Pharmaceutical Company and Darryl Wellinghoff dated as of February 25, 2019
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2020
Revenue Interest Agreement, dated May 10, 2018, among La Jolla Pharma, LLC, HealthCare Royalty Partners III, L.P., HCRP Overflow Fund, L.P. and HCR Molag Fund, L.P
LA JOLLA PHARMACEUTICAL CO
Biotechnology
NY
2018
Underwriting Agreement, dated March 14, 2018, between La Jolla Pharmaceutical Company and Cowen and Company, LLC
Underwriting Agreements
LA JOLLA PHARMACEUTICAL CO
2018
Amended and Restated Patent License Agreement by and between La Jolla Pharmaceutical Company and the George Washington University dated March 1, 2016
License Agreements
LA JOLLA PHARMACEUTICAL CO
2018
3,731,344 Shares LaJolla Pharmaceutical Company UNDERWRITING AGREEMENT
Underwriting Agreements
LA JOLLA PHARMACEUTICAL CO
2017
EXHIBIT A RELEASE AND WAIVER OF CLAIMS TO BE SIGNED AT TIME OF TERMINATION WITHOUT CAUSE OR RESIGNATION FOR GOOD REASON
Termination Agreements
LA JOLLA PHARMACEUTICAL CO
2016
2,550,000 Shares LaJolla Pharmaceutical Company UNDERWRITING AGREEMENT
Underwriting Agreements
LA JOLLA PHARMACEUTICAL CO
2015
Dated:March 16, 2015/s/ Dennis M. MulroyDennis M. Mulroy
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2015
4,800,000 Shares La Jolla Pharmaceutical Company UNDERWRITING AGREEMENT
Underwriting Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
NY
2014
CERTIFICATE OF DETERMINATION of SERIES FCONVERTIBLE PREFERRED STOCK of LA JOLLA PHARMACEUTICAL COMPANY Pursuant to Section 401 of the California General Corporation Law
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
2013
AMENDED AND RESTATED ARTICLES OF INCORPORATION OF LA JOLLAPHARMACEUTICAL COMPANY Pursuant to Section 910 of the California General Corporation Law
Articles of Amendment
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2013
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2013
CONSENT AND WAIVER AGREEMENT
Waiver Agreements
LA JOLLA PHARMACEUTICAL CO
2013
EXCHANGE AGREEMENT
Exchange Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2013
LA JOLLA PHARMACEUTICAL COMPANY RESTRICTED STOCK AGREEMENT
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2013
LA JOLLA PHARMACEUTICAL COMPANY 2013 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2013
CONSENT, WAIVER AND AMENDMENT AGREEMENT
Waiver Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2013
AGREEMENT AND PLAN OF MERGER OF LA JOLLA PHARMACEUTICAL COMPANY, ADELAWARE CORPORATION AND LJPC MERGER SUB, INC., A CALIFORNIA CORPORATION
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
2012
APPENDIX C 2010 Equity Incentive Plan LA JOLLA PHARMACEUTICAL COMPANY 2010 EQUITY INCENTIVE PLAN ARTICLE I GENERAL PROVISIONS
Equity Distribution Agreements
LA JOLLA PHARMACEUTICAL CO
2012
ASSET PURCHASE AGREEMENT
Purchase Agreements
LA JOLLA PHARMACEUTICAL CO
2012
CONSENT AND AMENDMENT AGREEMENT
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2012
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS
Separation Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2012
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS
Separation Agreements
LA JOLLA PHARMACEUTICAL CO
2012
LA JOLLA PHARMACEUTICAL COMPANY
LA JOLLA PHARMACEUTICAL CO
2012
SECOND AMENDMENT AGREEMENT
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2011
AMENDMENT AGREEMENT
LA JOLLA PHARMACEUTICAL CO
2011
ASSET PURCHASE AGREEMENT
Purchase Agreements
LA JOLLA PHARMACEUTICAL CO
2011
CONSENT AND AMENDMENT AGREEMENT
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2011
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2010
SECURITIES PURCHASE AGREEMENT Dated as of May 24, 2010 by and among LA JOLLA PHARMACEUTICAL COMPANY and THE PURCHASERS LISTED ON EXHIBIT A SECURITIES PURCHASE AGREEMENT
Purchase Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2010
FORM OF SERIES C-2 PREFERRED STOCK PURCHASE WARRANT LA JOLLA PHARMACEUTICAL COMPANY
Warrant Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2010
FORM OF SERIES D-1 PREFERRED STOCK PURCHASE WARRANT LA JOLLA PHARMACEUTICAL COMPANY
Warrant Agreements
LA JOLLA PHARMACEUTICAL CO
2010
FORM OF SERIES D-2 PREFERRED STOCK PURCHASE WARRANT LA JOLLA PHARMACEUTICAL COMPANY
Warrant Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2010
CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2010
CONFIDENTIAL RETENTION AGREEMENT
Retention Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2010
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2010
CONFIDENTIAL RETENTION AGREEMENT
Retention Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2010
VIA FACSIMILE AND EMAIL March 3, 2010 Adamis Pharmaceutical Corporation 2658 Del Mar Heights Road, #555 Del Mar, California 92014 Attention: President Re: Termination of Merger...
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2010
AGREEMENT AND PLAN OF REORGANIZATION among LA JOLLA PHARMACEUTICAL COMPANY a Delaware corporation, JEWEL MERGER SUB, INC., a Delaware corporation and ADAMIS PHARMACEUTICALS...
Merger Agreements
LA JOLLA PHARMACEUTICAL CO
2009
RETENTION AND SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS
Retention Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2009
RETENTION AND SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS
Retention Agreements
LA JOLLA PHARMACEUTICAL CO
2009
VOTING AGREEMENT
Voting Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2009
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2009
Current assets
LA JOLLA PHARMACEUTICAL CO
2009
Current assets
LA JOLLA PHARMACEUTICAL CO
2009
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2009
Sell or out-license our remaining assets, including our SSAO compounds, although we do not expect to receive any substantive value for them
LA JOLLA PHARMACEUTICAL CO
2009
AMENDMENT NO. 1 TO AMENDED AND RESTATED RIGHTS AGREEMENT
LA JOLLA PHARMACEUTICAL CO
2009
Entry into a Material Definitive Agreement
LA JOLLA PHARMACEUTICAL CO
2008
Entry into a Material Definitive Agreement
LA JOLLA PHARMACEUTICAL CO
2008
Entry into a Material Definitive Agreement
LA JOLLA PHARMACEUTICAL CO
Biotechnology
NY
2008
PROMISSORY NOTE
Note Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2008
* * *
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2008
Current assets
LA JOLLA PHARMACEUTICAL CO
2007
Current assets
LA JOLLA PHARMACEUTICAL CO
2007
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2007
Focus on higher doses all new patients entering the study will be randomized in equal numbers to receive weekly doses of either 300 mg or 900 mg of Riquent or placebo, with no...
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2007
Current assets
LA JOLLA PHARMACEUTICAL CO
2006
/s/ Michael Tansey 7/14/06 Michael Tansey, BSc, MB ChB, MD, FFPM Date
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2006
EXHIBIT 10.1 LA JOLLA PHARMACEUTICAL COMPANY 1995 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
2006
CHIEF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2006
SEPARATION AGREEMENT
Separation Agreements
LA JOLLA PHARMACEUTICAL CO
2006
LA JOLLA PHARMACEUTICAL COMPANY 2004 EQUITY INCENTIVE PLAN ARTICLE I GENERAL PROVISIONS
Bonus & Incentive Agreements
LA JOLLA PHARMACEUTICAL CO
2006
AMENDMENT NO. 3 TO RIGHTS AGREEMENT
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2006
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
LA JOLLA PHARMACEUTICAL CO
2006
AMENDMENT NO. 2 TO RIGHTS AGREEMENT
LA JOLLA PHARMACEUTICAL CO
2005
LA JOLLA PHARMACEUTICAL COMPANY 2004 EQUITY INCENTIVE PLAN ARTICLE I GENERAL PROVISIONS
Bonus & Incentive Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
DE
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
EXHIBIT 10.1 LA JOLLA PHARMACEUTICAL COMPANY 2004 EQUITY INCENTIVE PLAN ARTICLE I GENERAL PROVISIONS
Bonus & Incentive Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
EXHIBIT 10.2 LA JOLLA PHARMACEUTICAL COMPANY 1995 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
2005
Entry Into A Material Definitive Agreement
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
2004
Current assets
LA JOLLA PHARMACEUTICAL CO
2004
Exhibit No
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2004
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
Exhibit No
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
Form of Stock Purchase Agreement between the Company and Purchasers
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2002
Form of Stock Purchase Agreement between the Company and Purchasers
Stock Agreements
LA JOLLA PHARMACEUTICAL CO
Biotechnology
CA
2002
Focus on higher doses all new patients entering the study will be randomized in equal numbers to receive weekly doses of either 300 mg or 900 mg of Riquent or placebo, with no...
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2007
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2005
Current assets
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2004
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
2003
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2002
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2001
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2001
PART I. FINANCIAL INFORMATION
LA JOLLA PHARMACEUTICAL CO
Biotechnology
2001